Incorrect Data in Tables and Figures. In the Original Contribution entitled "Early and Sustained Dual Oral
Antiplatelet Therapy Following Percutaneous Coronary Intervention" published
in the November 20, 2002, issue of THE JOURNAL (2002;288:2411-2420), there
were incorrect numbers in several tables and figures. In Table 1 on page 2414,
the data for statin use should have read 563 (53.5%) for clopidogrel and 609
(57.3%) for placebo, with a P value of .08. In the
top half (1-year data) of Table 3 on page 2417, numbers of clopidogrel patients
for CABG and non-CABG bleeding should have read 63 and 18, respectively. In
the bottom half (28-day data) of Table 3, data for any major bleeding should
have read 50 (4.7%) for clopidogrel and 38 (3.6%) for placebo, with a P value of .19. Data for nonprocedural major bleeding should
have read 3 (0.3%) for placebo, with a P value of
.62. Data for procedural major bleeding should have read 49 (4.7%) for clopidogrel
and 35 (3.3%) for placebo, with a P value of .11.
Data for any minor bleeding should have read 33 (3.1%) for clopidogrel and
24 (2.3%) for placebo, with a P value of .23. Data
for procedural minor bleeding should have read 30 (2.9%) for clopidogrel and
23 (2.2%) for placebo, with a P value of .33.